Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Travere Therapeutics Inc (TVTX)

Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 468,955
  • Shares Outstanding, K 76,129
  • Annual Sales, $ 145,240 K
  • Annual Income, $ -111,400 K
  • 60-Month Beta 0.69
  • Price/Sales 3.32
  • Price/Cash Flow N/A
  • Price/Book 6.51
Trade TVTX with:

Options Overview Details

View History
  • Implied Volatility 68.36% ( -28.61%)
  • Historical Volatility 60.03%
  • IV Percentile 26%
  • IV Rank 13.72%
  • IV High 264.14% on 09/20/23
  • IV Low 37.24% on 05/20/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 481
  • Put/Call OI Ratio 1.76
  • Today's Open Interest 9,946
  • Open Int (30-Day) 10,461

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.84
  • Number of Estimates 9
  • High Estimate -0.44
  • Low Estimate -1.06
  • Prior Year -1.13
  • Growth Rate Est. (year over year) +25.66%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.12 +20.31%
on 04/25/24
7.69 -19.90%
on 05/07/24
+0.71 (+13.03%)
since 04/24/24
3-Month
5.12 +20.31%
on 04/25/24
9.03 -31.78%
on 03/08/24
-1.78 (-22.42%)
since 02/23/24
52-Week
5.12 +20.31%
on 04/25/24
19.54 -68.48%
on 06/06/23
-10.62 (-63.29%)
since 05/24/23

Most Recent Stories

More News
CSL Vifor and Travere Therapeutics Announce European Commission approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy

/CNW/ -- CSL Vifor and Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that the European Commission has granted conditional marketing authorization...

TVTX : 6.16 (-2.84%)
CSL Vifor and Travere Therapeutics announce sparsentan receives positive CHMP opinion for the treatment of IgA nephropathy

/CNW/ -- CSL Vifor and Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that the European Medicines Agency's (EMA) CHMP has recommended approval of...

TVTX : 6.16 (-2.84%)
Why Shares of Travere Therapeutics Are Slumping Thursday

A mixed trial could hurt a kidney drug's chances of full approval.

MIRM : 24.55 (-3.61%)
TVTX : 6.16 (-2.84%)
3 Small-Cap Stocks That Could Be Big-Time Winners

These stocks come with significant risks. But they could generate huge returns over time.

BLUE : 0.9664 (-0.29%)
TVTX : 6.16 (-2.84%)
VKTX : 62.75 (+1.92%)
TVTX ALERT: The Law Offices of Vincent Wong Investigate Travere Therapeutics, Inc. for Potential Violations of Securities Laws

/PRNewswire/ -- Attention Travere Therapeutics, Inc. ("Travere") (NASDAQ: TVTX) shareholders: The Law Offices of Vincent Wong announce that an investigation...

TVTX : 6.16 (-2.84%)
TVTX FRAUD ALERT: Jakubowitz Law is Investigating Travere Therapeutics, Inc. in Connection with Potential Violations of Federal Securities Laws

/PRNewswire/ -- Jakubowitz Law announces that an investigation into potential securities fraud allegations has commenced on behalf of shareholders of Travere...

TVTX : 6.16 (-2.84%)
TVTX INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of Travere Therapeutics, Inc.

/PRNewswire/ -- Levi & Korsinsky notifies investors that it has commenced an investigation of Travere Therapeutics, Inc. ("Travere") (NASDAQ: TVTX) concerning...

TVTX : 6.16 (-2.84%)
TVTX NEWS: The Klein Law Firm Initiates an Investigation Involving Possible Securities Fraud Violations by Officers of Travere Therapeutics, Inc.

/PRNewswire/ -- The Klein Law Firm announces that it is investigating allegations that Travere Therapeutics, Inc. ("Travere") (NASDAQ: TVTX) violated federal...

TVTX : 6.16 (-2.84%)
TVTX ALERT: The Law Offices of Vincent Wong Investigate Travere Therapeutics, Inc. for Potential Violations of Securities Laws

/PRNewswire/ -- Attention Travere Therapeutics, Inc. ("Travere") (NASDAQ: TVTX) shareholders: The Law Offices of Vincent Wong announce that an investigation...

TVTX : 6.16 (-2.84%)
TVTX INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of Travere Therapeutics, Inc.

/PRNewswire/ -- Levi & Korsinsky notifies investors that it has commenced an investigation of Travere Therapeutics, Inc. ("Travere") (NASDAQ: TVTX) concerning...

TVTX : 6.16 (-2.84%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Travere Therapeutics Inc. is a biopharmaceutical company. It engages to identify, develop and deliver life-changing therapies. Travere Therapeutics Inc., formerly known as Retrophin Inc., is based in SAN DIEGO.

See More

Key Turning Points

3rd Resistance Point 6.57
2nd Resistance Point 6.48
1st Resistance Point 6.32
Last Price 6.16
1st Support Level 6.07
2nd Support Level 5.98
3rd Support Level 5.82

See More

52-Week High 19.54
Fibonacci 61.8% 14.03
Fibonacci 50% 12.33
Fibonacci 38.2% 10.63
Last Price 6.16
52-Week Low 5.12

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar